Saturday 17 October 2026
Export LFMD’s income statement to Excel — free account
LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
2.34
0.12
−4.88%
Follow LFMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.12 |
Piotroski F-Score |
3 | 5 | 5 | 3 | 3 | 4 | 5 | 6 | 4 | 6 |
Altman Z-Score |
(11.47) | 1.51 | (3.65) | (5.54) | (16.03) | (2.58) | (11.19) | 0.01 | (2.04) | (0.02) |
P/S ratio |
1.53 | 4.08 | 0.74 | 0.48 | 2.50 | 1.13 | 0.49 | 1.87 | 1.32 | 0.79 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 23.62 | 0.00 | 0.00 | 0.00 | 3,289.06 | 21.91 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(53.34) | (30.40) | (18.90) | (23.93) | (49.29) | (12.55) | (40.94) | (12.62) | (13.47) | (9.85) |
P/Operating CF |
(27.13) | (29.96) | (14.86) | 37.37 | (14.26) | (17.94) | (29.73) | 50.02 | 189.99 | (46.91) |
Beneish M-Score |
(4.98) | (5.27) | (4.39) | (8.02) | (15.84) | (3.83) | (3.73) | (4.04) | (4.06) | (3.67) |
P/B ratio |
0.00 | 24.13 | 7.55 | 0.00 | 0.00 | 4.81 | 0.00 | 51.35 | 0.00 | 6.65 |
Price to Tangible BV |
0.00 | 24.13 | 0.00 | 0.00 | 0.00 | 4.82 | 0.00 | 111.79 | 0.00 | 6.72 |
EV/Sales |
1.52 | 4.07 | 0.73 | 0.46 | 2.28 | 0.70 | 0.49 | 1.78 | 1.22 | 0.68 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(19.50) | (18.34) | (6.70) | 22.58 | (7.01) | (1.97) | (2.56) | 30.81 | 10.83 | 16.01 |
EV/FCF |
(19.50) | (18.34) | (6.70) | 22.58 | (6.76) | (1.78) | (1.64) | 3,127.18 | 20.37 | (106.73) |
Quick Ratio |
0.55 | 0.42 | 0.23 | 0.30 | 0.73 | 1.85 | 0.22 | 1.10 | 0.64 | 1.11 |
Current Ratio |
0.69 | 1.97 | 1.35 | 0.69 | 0.89 | 1.97 | 0.36 | 1.22 | 0.78 | 1.25 |
Net Debt/EBITDA |
0.07 | (0.02) | (0.04) | 0.14 | 0.14 | 0.77 | (0.01) | 2.01 | 1.04 | 289.88 |
Debt/Assets |
12.66% | 13.25% | 9.46% | 24.51% | 7.94% | 3.70% | 16.08% | 30.66% | 24.09% | 0.00% |
Debt/Equity |
(0.28) | 0.27 | 0.30 | (0.75) | (1.30) | 0.07 | (0.56) | 3.22 | (2.43) | 0.00 |
Asset Turnover |
8.46 | 3.59 | 4.29 | 4.11 | 4.43 | 2.93 | 3.15 | 3.63 | 2.30 | 2.65 |
Operating CF/Net income |
0.37 | 0.68 | 0.73 | (0.08) | 0.19 | 0.54 | 0.47 | (0.37) | (0.71) | 0.74 |
Capex/Depreciation |
0.00 | 0.00 | (0.20) | 0.00 | (0.33) | (1.15) | (1.02) | (1.26) | (1.24) | (1.26) |
Interest Coverage |
(24.17) | (12.22) | (5.80) | (3.80) | (34.67) | (17.98) | (34.05) | (5.58) | (9.38) | (5.64) |
| 1,225.79% | (923.78%) | (172.03%) | 2,027.27% | 2,260.22% | (716.97%) | (988.99%) | 751.79% | 2,465.96% | 144.18% | |
| (178.87%) | (117.45%) | (63.96%) | (103.50%) | (752.12%) | (195.08%) | (128.70%) | (56.34%) | (36.43%) | 15.35% | |
ROIC |
0.00% | (118.32%) | (144.88%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
306.19% | (193.64%) | (300.65%) | 260.41% | 5,088.17% | (276.62%) | 248.35% | (285.61%) | 180.38% | 88.55% |
Average Days of Receivables |
31.14 | 12.71 | 4.35 | 2.85 | 9.77 | 3.85 | 8.69 | 12.63 | 24.65 | 17.50 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 1.45% | 1.79% | 1.20% | 1.02% | 2.50% | 3.97% | 4.43% | 3.79% |
Selling, General and Administrative Expense of Revenue |
85.27% | 105.72% | 88.51% | 90.75% | 225.27% | 131.44% | 105.29% | 84.00% | 82.71% | 74.21% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.39 | 0.20 | 0.03 | 0.00 | 0.15 | 0.05 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
11.22% | 27.21% | 8.48% | 6.01% | 99.11% | 13.00% | 12.22% | 8.54% | 7.90% | 5.41% |
Graham Net Nets |
(0.04) | 0.04 | (0.03) | (0.31) | (0.02) | 0.20 | (0.37) | (0.04) | (0.15) | 0.03 |
Graham Number |
0.45 | 0.00 | 0.00 | 0.94 | 5.80 | 0.00 | 3.68 | 0.00 | 1.49 | 1.73 |
Earnings Yield |
(13.82%) | (8.82%) | (25.34%) | (57.47%) | (72.89%) | (58.66%) | (83.07%) | (8.30%) | (10.91%) | 7.62% |
Free Cash Flow Yield |
(5.08%) | (5.44%) | (14.64%) | 4.23% | (13.51%) | (34.89%) | (61.20%) | 0.03% | 4.56% | (0.81%) |
Revenue per Share |
0.78 | 0.44 | 0.94 | 1.26 | 2.61 | 3.44 | 3.84 | 4.50 | 3.76 | 4.30 |
Operating CF per Share |
(0.06) | (0.10) | (0.10) | 0.03 | (0.85) | (1.22) | (0.74) | 0.26 | 0.43 | 0.18 |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | (0.03) | (0.13) | (0.42) | (0.26) | (0.20) | (0.21) |
Free Cash Flow per Share |
(0.06) | (0.10) | (0.11) | 0.03 | (0.88) | (1.35) | (1.16) | 0.00 | 0.23 | (0.03) |
Cash per Share |
0.03 | 0.02 | 0.02 | 0.11 | 0.64 | 1.53 | 0.13 | 0.98 | 0.79 | 0.82 |
Shareholders Equity per Share |
(0.05) | 0.07 | 0.09 | (0.11) | (0.06) | 0.96 | (0.24) | 0.16 | (0.18) | 0.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.05) | 0.07 | 0.09 | (0.11) | (0.06) | 0.96 | (0.24) | 0.16 | (0.18) | 0.51 |
Free Cash Flow |
(0.41) | (0.82) | (1.01) | 0.25 | (12.53) | (36.49) | (35.83) | 0.09 | 9.31 | (1.24) |
Working Capital |
(0.36) | 0.62 | 0.41 | (1.23) | (1.52) | 22.10 | (20.06) | 7.82 | (15.03) | 10.26 |
Capital Expenditures |
— | — | (0.10) | — | (0.40) | (3.40) | (12.89) | (8.73) | (8.21) | (9.52) |
Net Current Asset Value |
(0.36) | 0.62 | (0.19) | (1.83) | (1.81) | 20.82 | (21.66) | (10.31) | (31.28) | 4.58 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.04 | 0.11 | 0.06 | 0.05 | 0.05 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 40.59 | 4.43 | 12.66 | 26.52 | 14.56 | 4.58 | 3.09 |
Cash ROIC |
515.68% | (87.71%) | (80.62%) | 30.58% | (132.99%) | (52.88%) | (4,588.69%) | 0.15% | 21.43% | (2.07%) |
Accounts Receivable Turnover |
17.42 | 12.80 | 73.24 | 126.91 | 68.10 | 93.91 | 62.40 | 37.61 | 19.68 | 19.64 |
Accounts Payable Turnover |
4.23 | 1.73 | 3.09 | 1.29 | 1.17 | 1.70 | 1.95 | 1.78 | 1.95 | 2.21 |
Inventory Turnover |
17.58 | 2.42 | 2.34 | 2.56 | 8.00 | 12.49 | 7.02 | 5.85 | 7.72 | 9.95 |
Average Days of Payables |
141.21 | 151.43 | 158.89 | 441.01 | 500.20 | 183.75 | 197.61 | 214.07 | 185.64 | 186.34 |
Days of Inventory on Hand |
30.07 | 244.30 | 186.98 | 137.32 | 52.08 | 32.79 | 72.41 | 53.30 | 47.62 | 36.53 |
Average Receivables |
0.30 | 0.29 | 0.11 | 0.10 | 0.55 | 0.99 | 1.91 | 4.06 | 7.87 | 9.88 |
Average Payables |
0.46 | 0.59 | 0.65 | 1.96 | 7.60 | 10.60 | 9.58 | 10.60 | 10.99 | 12.53 |
Average Inventory |
0.11 | 0.42 | 0.85 | 0.99 | 1.11 | 1.44 | 2.66 | 3.23 | 2.78 | 2.79 |
Average Assets |
0.62 | 1.03 | 1.94 | 3.03 | 8.42 | 31.66 | 37.79 | 42.07 | 67.29 | 73.25 |
Average Common Equity |
(0.09) | 0.13 | 0.72 | (0.15) | (2.80) | 8.62 | 4.92 | (3.15) | (0.99) | 7.80 |
Columns are period end dates